Some aspects of studies with oral contraceptives in Indian women.
Shah
P N
PN
D000568:Amenorrhea; D000858:Anovulation; D001208:Asia; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003710:Demography; D003906:Developing Countries; D004194:Disease; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D005298:Fertility; D005835:Genitalia; D005836:Genitalia, Female; D007194:India; D008099:Liver; D008599:Menstruation Disturbances; D008656:Mestranol; D008660:Metabolism; D009640:Norethindrone; D009641:Norethynodrel; D010053:Ovary; D010342:Patient Acceptance of Health Care; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D012106:Research; D012725:Sexual Behavior; D013256:Steroids; D014566:Urogenital System
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D013256:Steroids; D004997:Ethinyl Estradiol; D009641:Norethynodrel; D008656:Mestranol; D009640:Norethindrone
Acceptor Characteristics; Amenorrhea; Anovulation; Asia; Biology; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Demographic Factors; Developing Countries; Diseases; Ethinyl Estradiol; Family Planning; Fertility; Genitalia; Genitalia, Female; Hepatic Effects; India; Menstruation Disorders; Mestranol; Metabolic Effects; Norethindrone; Norethindrone Acetate; Norethynodrel; Oral Contraceptives; Oral Contraceptives, Combined; Oral Contraceptives, Phasic; Ovarian Effects; Ovary; Physiology; Population; Population Dynamics; Pregnancy, Planned; Reproductive Behavior; Research Methodology; Reversibility; Southern Asia; Steroid Metabolic Effects; Urogenital System